Scientists have redesigned a key protein from the novel coronavirus which it uses to enter and infect human cells, an innovation that may lead to much faster and more stable production of vaccines against COVID-19.<br />''<br />''According to the researchers, including those from the University of Texas at Austin in the US, most COVID-19 vaccine candidates train the human immune system to recognise a key protein on the surface of the novel coronavirus SARS-CoV-2 called the spike (S) protein to fight infection.<br />''<br />''In the current study, published in the journal Science, the scientists designed a new version of this protein which can be produced up to 10 times more in cells than that of an earlier synthetic S protein already in use in multiple COVID-19 vaccines.<br />''Depending on the type of vaccine, this improved version of the protein could reduce the size of each dose or speed up vaccine production.<br />'' <br />''Either way, it could mean more patients have access to vaccines faster said Jason McLellan from the University of Texas at Austin.<br />'' <br />''The new protein, dubbed HexaPro, is also more stable than the team's earlier version of the S protein, which according to the scientists should make it easier to store and transport.<br />